301515 港通医疗
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)-0.8161.1048.82614.24215.757
总资产报酬率 ROA (%)-0.5090.7315.2596.8247.466
投入资产回报率 ROIC (%)-0.5690.8376.3238.7049.425

边际利润分析
销售毛利率 (%)22.45119.87025.78529.24527.401
营业利润率 (%)-4.5711.76811.55010.87711.366
息税前利润/营业总收入 (%)-4.3301.43511.21211.38912.511
净利润/营业总收入 (%)-3.4371.9139.8649.61910.519

收益指标分析
经营活动净收益/利润总额(%)-14.802350.168109.134134.430106.459
价值变动净收益/利润总额(%)-2.1526.3401.2690.0000.052
营业外收支净额/利润总额(%)-1.86711.710-2.571-0.3495.098

偿债能力分析
流动比率 (X)2.3922.7972.8901.7481.720
速动比率 (X)1.9732.4652.4191.3761.223
资产负债率 (%)40.94134.00133.45452.35051.774
带息债务/全部投入资本 (%)32.66423.41720.46635.03134.755
股东权益/带息债务 (%)200.638317.762377.358174.275176.078
股东权益/负债合计 (%)144.327194.113198.91791.02193.149
利息保障倍数 (X)-27.489-2.531-228.73420.70923.423

营运能力分析
应收账款周转天数 (天)548.368338.041274.977235.468203.500
存货周转天数 (天)264.479148.932146.131150.252172.436